Fish Oil and Vitamin D Supplementations in Pregnancy Protect Against Childhood Croup

J Allergy Clin Immunol Pract. 2023 Jan;11(1):315-321. doi: 10.1016/j.jaip.2022.09.027. Epub 2022 Sep 30.

Abstract

Background: Croup is a prevalent respiratory disorder in early childhood most often caused by parainfluenza virus infections. There are no preventive strategies; therefore, we investigated the potential effects of prenatal micronutrient supplementations.

Objective: To investigate the supplementation effects of (1) 2.4-g n-3 long-chained polyunsaturated fatty acid (n-3 LCPUFA) (fish oil) versus olive oil and (2) high-dose (2800 IU/d) versus standard-dose (400 IU/d) of vitamin D from pregnancy week 24 until 1 week after birth on the risk for offspring croup during the double-blinded first 3 years of life in a secondary analysis of a 2 × 2 factorial designed randomized controlled trial.

Methods: The study was completed in the Danish population-based single-center Copenhagen Prospective Studies on Asthma in Childhood 2010 mother-child cohort, which included 736 pregnant women. Croup was diagnosed by physicians' clinical examinations and medical record checks. Potential mediating mechanisms were investigated using blood metabolomics, airway cytokines, and airway microbiome.

Results: Of 695 children, 97 had croup before age 3 years (14%). The risk of croup was reduced in the n-3 LCPUFA (ncases / ntotal = 38/346; 11%) versus olive oil group (59 of 349 children; 17%) (hazard ratio = 0.62; 95% CI, 0.41-0.93; P = .02) and in the high-dose vitamin D group (32 of 295 children; 11%) versus the standard-dose group (51 of 286 children; 18%) (hazard ratio = 0.60; 95% CI, 0.38-0.93; P = .02). There was no evidence of interaction or additive effects between the supplements (Pinteraction = .56). Furthermore, the results did not change when they were adjusted for each other, persistent wheeze, and lower respiratory tract infection.

Conclusions: This analysis of the double-blinded period of the Copenhagen Prospective Studies on Asthma in Childhood 2010 randomized controlled trial of n-3 LCPUFA and high-dose vitamin D supplementation during pregnancy demonstrated a reduced risk of croup in early childhood.

Trial registration: ClinicalTrials.gov NCT00798226 NCT00856947.

Keywords: COPSAC; Croup; Fish oil; PUFA; RCT; Vitamin D.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma* / prevention & control
  • Child, Preschool
  • Croup*
  • Dietary Supplements
  • Fatty Acids, Omega-3*
  • Female
  • Fish Oils / therapeutic use
  • Humans
  • Olive Oil / therapeutic use
  • Pregnancy
  • Prospective Studies
  • Respiratory Tract Infections*
  • Vitamin D / therapeutic use
  • Vitamins

Substances

  • Fish Oils
  • Olive Oil
  • Fatty Acids, Omega-3
  • Vitamins
  • Vitamin D

Associated data

  • ClinicalTrials.gov/NCT00798226
  • ClinicalTrials.gov/NCT00856947